WEBVTT - NatWest Rises, GSK Drops, Accor Up 

0:00:02.520 --> 0:00:08.720
<v Speaker 1>Bloomberg Audio Studios, podcasts, radio news, The.

0:00:08.720 --> 0:00:12.560
<v Speaker 2>Stock Movers Report, your roundup of companies making moves in

0:00:12.600 --> 0:00:15.880
<v Speaker 2>the stock market, harnessing the power of Bloomberg Data.

0:00:16.640 --> 0:00:18.520
<v Speaker 3>Let's have a look at some stocks on the move

0:00:18.600 --> 0:00:21.200
<v Speaker 3>today Here in EUP, I'm Caroline Hepgar with Tom McKenzie.

0:00:21.200 --> 0:00:24.799
<v Speaker 3>We're joined by Bloomberg's Breaking News editor Louise Moon. Good morning, Louise.

0:00:25.160 --> 0:00:27.960
<v Speaker 3>Let's start by thinking about Matt West earnings. A beat

0:00:28.000 --> 0:00:31.800
<v Speaker 3>on operating profit, pretty pretty strong set of results, right,

0:00:31.840 --> 0:00:33.199
<v Speaker 3>what do investors make of it?

0:00:33.400 --> 0:00:36.239
<v Speaker 1>Indeed, yeah, investors are seemingly very happy. She shares a

0:00:36.280 --> 0:00:38.479
<v Speaker 1>sort of fifteen year high this morning on the back

0:00:38.520 --> 0:00:40.879
<v Speaker 1>of that. So as you say, they're third quarter results

0:00:40.920 --> 0:00:44.800
<v Speaker 1>beating estimates across the board really on a number of metrics,

0:00:44.800 --> 0:00:47.880
<v Speaker 1>So taking pretext profit for example, it was thirty percent

0:00:48.000 --> 0:00:50.760
<v Speaker 1>higher than last year, and this is the highest earnings

0:00:51.120 --> 0:00:53.960
<v Speaker 1>in at least a decade. So a strong set of results,

0:00:54.040 --> 0:00:57.640
<v Speaker 1>essentially benefiting from higher interest rates or continued at higher

0:00:57.720 --> 0:00:59.840
<v Speaker 1>interest rates. And there was a on top of that

0:01:00.120 --> 0:01:02.480
<v Speaker 1>quote from the CEO saying they're becoming a much simpler

0:01:02.520 --> 0:01:06.520
<v Speaker 1>bank with tight control of costs, supporting the digital transformation,

0:01:06.680 --> 0:01:10.800
<v Speaker 1>so a bit of a transformation and interest rates benefiting them.

0:01:10.920 --> 0:01:13.360
<v Speaker 1>If you compare it, compare it to Lloyd's for example, yesday,

0:01:13.360 --> 0:01:15.640
<v Speaker 1>we've had we've had a host of banking updates this week.

0:01:15.680 --> 0:01:16.880
<v Speaker 1>If you compared it to Lloyds yesday, it was a

0:01:16.880 --> 0:01:19.679
<v Speaker 1>lot more positive. But obviously it has to be noted

0:01:19.680 --> 0:01:21.759
<v Speaker 1>that Lloyds took a big hit from the motor provision

0:01:22.440 --> 0:01:26.759
<v Speaker 1>Moti finance provision. But if you take a step back

0:01:26.760 --> 0:01:29.200
<v Speaker 1>and look at all the earnings, essentially they're they're kind

0:01:29.240 --> 0:01:32.840
<v Speaker 1>of signaling that Brits or customers are coping well with

0:01:33.120 --> 0:01:35.280
<v Speaker 1>the economic headwinds at the moment. And then we had

0:01:35.319 --> 0:01:37.160
<v Speaker 1>retail Stata this morning that pointed to it to a

0:01:37.160 --> 0:01:39.320
<v Speaker 1>similar kind of trend. And we've got more coming next

0:01:39.360 --> 0:01:42.280
<v Speaker 1>week to got HSBC and Standard Chartered coming next week,

0:01:42.280 --> 0:01:44.319
<v Speaker 1>but so far coming in quite strong.

0:01:44.360 --> 0:01:47.240
<v Speaker 4>And that was really strong this morning and Louise in

0:01:47.319 --> 0:01:50.160
<v Speaker 4>the drug space and the pharmaceutical space, GSK shares dropping

0:01:50.240 --> 0:01:53.480
<v Speaker 4>there about one point six percent right now. What is

0:01:53.480 --> 0:01:55.520
<v Speaker 4>behind the drop and the fall in the stock price

0:01:55.560 --> 0:01:57.440
<v Speaker 4>for GSK, So when you first look at it seems

0:01:57.480 --> 0:01:58.240
<v Speaker 4>like positive news.

0:01:58.240 --> 0:02:01.800
<v Speaker 1>So US regulators have approved GSK's blood cancer drug that's

0:02:01.800 --> 0:02:04.000
<v Speaker 1>called blend Rep, so they can obviously now bring that

0:02:04.040 --> 0:02:07.440
<v Speaker 1>medicine to the US, which is the world's biggest pharmaceutical market.

0:02:07.680 --> 0:02:09.639
<v Speaker 1>That they had pulled the drug in twenty twenty two,

0:02:09.919 --> 0:02:12.359
<v Speaker 1>there were questions about how effective it was, but now

0:02:12.440 --> 0:02:14.760
<v Speaker 1>they can now bring that back to the market, so

0:02:14.800 --> 0:02:18.080
<v Speaker 1>it's quite important milestone. The drug is very critical to

0:02:18.200 --> 0:02:21.520
<v Speaker 1>GSK's revenue ambitions. But as you say, shares are dropping

0:02:21.560 --> 0:02:23.919
<v Speaker 1>that they're dragging the footze hundred this morning in London.

0:02:24.480 --> 0:02:27.760
<v Speaker 1>This is because despite being improved that there are a

0:02:27.760 --> 0:02:29.880
<v Speaker 1>lot of caveats that have come with that approval, So

0:02:30.280 --> 0:02:32.680
<v Speaker 1>the eligibility Paul of who can use it is smaller

0:02:32.680 --> 0:02:33.360
<v Speaker 1>than expected.

0:02:34.600 --> 0:02:37.399
<v Speaker 4>It can now be used for slightly in slightly.

0:02:37.080 --> 0:02:40.000
<v Speaker 1>More advanced scenarios that than had been expected, so there

0:02:40.040 --> 0:02:43.760
<v Speaker 1>are concerns about the potential for sale, so the viability

0:02:43.760 --> 0:02:47.120
<v Speaker 1>of its commercial opportunity. So that's what's really dragging the

0:02:47.120 --> 0:02:49.840
<v Speaker 1>shares this morning, despite that that important milestone being reached.

0:02:50.919 --> 0:02:54.960
<v Speaker 3>Meanwhile, our core shares gaining after the hotelier's a guidance

0:02:55.160 --> 0:02:56.160
<v Speaker 3>was increased.

0:02:56.480 --> 0:02:58.560
<v Speaker 1>Yeah, raised guidance this morning essentially on the back of

0:02:58.639 --> 0:03:01.360
<v Speaker 1>cost savings, so they've been simplifying of their portfolio. There

0:03:01.440 --> 0:03:03.880
<v Speaker 1>was also a host of other positive news alongside their earnings,

0:03:03.880 --> 0:03:06.519
<v Speaker 1>so they issued a new buyback that's one hundred million euros.

0:03:06.560 --> 0:03:07.519
<v Speaker 4>That's for the fourth quarter.

0:03:07.840 --> 0:03:12.320
<v Speaker 1>They also might list their lifestyle brands portfolio that has

0:03:12.360 --> 0:03:14.919
<v Speaker 1>been touted before, but they've confirmed that this morning.

0:03:15.080 --> 0:03:16.800
<v Speaker 4>And this is all with their third quarter earnings.

0:03:16.840 --> 0:03:19.600
<v Speaker 1>They came in line with esmates quite positive comments about

0:03:19.639 --> 0:03:23.160
<v Speaker 1>their current trading. There is still some potential weaknesses there

0:03:23.160 --> 0:03:26.240
<v Speaker 1>in some large markets like Germany and China, but shares

0:03:26.400 --> 0:03:29.240
<v Speaker 1>shot up in France and are now slightly higher than

0:03:29.240 --> 0:03:32.560
<v Speaker 1>a year ago, kind of continuing that positive trajectory.

0:03:33.600 --> 0:03:37.640
<v Speaker 2>The Stock Movers report from Bloomberg Radio. Check back with

0:03:37.720 --> 0:03:40.280
<v Speaker 2>us throughout the day for the latest roundup of companies

0:03:40.360 --> 0:03:43.440
<v Speaker 2>making news on Wall Street and for the latest market

0:03:43.480 --> 0:03:47.920
<v Speaker 2>moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,

0:03:48.040 --> 0:03:51.560
<v Speaker 2>Bloomberg dot com, and on Applecarplay and Android Auto with

0:03:51.600 --> 0:03:53.120
<v Speaker 2>the Bloomberg Business app.